Regenerative medicine has become a major field of medical practice over the past few decades. But for most, these non-invasive and holistic treatments have remained inaccessible. Now, that’s starting ...
The accelerating pace of U.S. FDA approvals for cell and gene therapies is “great for the field and great news for the patients,” but questions remain over commercialization, with “costs remaining ...
Osteoarthritis (OA) remains one of the leading causes of disability worldwide, burdening health systems and diminishing quality of life ...
Regenerative medicine combines tissue engineering and cell therapies to repair or replace damaged human tissues and organs. Key applications include treating osteoarthritis with mesenchymal stem cells ...
The DRIVE-RM consortium, led by Professor of Experimental Nephrology Marianne Verhaar from UMC Utrecht, has been awarded €37.5 million under the prestigious NWO SUMMIT program. The SUMMIT grant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback